2014, ER, Individual and Insurance

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2014

Individual

Insurance

Exposure to high-priority drug-drug interactions among non-elderly adults in Quebec: a cohort study [Prescribing and pharmacotherapeutics]

Annals of Family Medicine

NOVEMBER 20, 2024

DDI exposures were considered incident if the individual was not exposed to a DDI in the year preceding cohort entry. Population: a 5% random sample of adult (19-64y) Quebec residents covered by the public drug insurance in 2014-2017 was used. Results: 1) 11.7% (95% CI: 11.5-12.0) Conclusions: One in 8.5

Primary Care

Primary Care Emergency Room Insurance ER

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law

SEPTEMBER 6, 2021

Briefly (more detail is available here ), GSK sued Teva back in 2014 alleging that Teva induced infringement of a method-of-use patent when Teva marketed a skinny-labeled generic version of GSK’s Coreg (carvedilol) as AB-rated. Instead, it was GSK who erred in omitting the post-MI language from the use code.

IT Provider ER Insurance

Primary Care Digest

Exposure to high-priority drug-drug interactions among non-elderly adults in Quebec: a cohort study [Prescribing and pharmacotherapeutics]

Ding Dong is the Skinny Label (Effectively) Dead?

Stay Connected